2,2-difluoro-3-hydroxy-6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-3,5-dihydrofuro[3,2-f]isoindol-7-one;3,3-difluoro-7-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-2,8-dihydro-[1,4]dioxino[2,3-f]isoindol-6-one;2,2-dimethyl-6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-5H-[1,3]dioxolo[4,5-f]isoindol-7-one;6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]spiro[3,5-dihydrofuro[3,2-f]isoindole-2,1'-cyclobutane]-7-one;6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]spiro[5H-[1,3]dioxolo[4,5-f]isoindole-2,1'-cyclobutane]-7-one;6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]spiro[5H-[1,3]dioxolo[4,5-f]isoindole-2,1'-cyclopropane]-7-one
C133H124F4N24O17 — CID 158838584
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2,2-difluoro-3-hydroxy-6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-3,5-dihydrofuro[3,2-f]isoindol-7-one;3,3-difluoro-7-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-2,8-dihydro-[1,4]dioxino[2,3-f]isoindol-6-one;2,2-dimethyl-6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-5H-[1,3]dioxolo[4,5-f]isoindol-7-one;6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]spiro[3,5-dihydrofuro[3,2-f]isoindole-2,1'-cyclobutane]-7-one;6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]spiro[5H-[1,3]dioxolo[4,5-f]isoindole-2,1'-cyclobutane]-7-one;6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]spiro[5H-[1,3]dioxolo[4,5-f]isoindole-2,1'-cyclopropane]-7-one
2,2-difluoro-3-hydroxy-6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-3,5-dihydrofuro[3,2-f]isoindol-7-one;3,3-difluoro-7-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-2,8-dihydro-[1,4]dioxino[2,3-f]isoindol-6-one;2,2-dimethyl-6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-5H-[1,3]dioxolo[4,5-f]isoindol-7-one;6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]spiro[3,5-dihydrofuro[3,2-f]isoindole-2,1'-cyclobutane]-7-one;6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]spiro[5H-[1,3]dioxolo[4,5-f]isoindole-2,1'-cyclobutane]-7-one;6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]spiro[5H-[1,3]dioxolo[4,5-f]isoindole-2,1'-cyclopropane]-7-one (PubChem CID 158838584) has the molecular formula C133H124F4N24O17 and a molecular weight of 2406.60 g/mol. Its IUPAC name is 2,2-difluoro-3-hydroxy-6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-3,5-dihydrofuro[3,2-f]isoindol-7-one;3,3-difluoro-7-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-2,8-dihydro-[1,4]dioxino[2,3-f]isoindol-6-one;2,2-dimethyl-6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-5H-[1,3]dioxolo[4,5-f]isoindol-7-one;6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]spiro[3,5-dihydrofuro[3,2-f]isoindole-2,1'-cyclobutane]-7-one;6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]spiro[5H-[1,3]dioxolo[4,5-f]isoindole-2,1'-cyclobutane]-7-one;6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]spiro[5H-[1,3]dioxolo[4,5-f]isoindole-2,1'-cyclopropane]-7-one.
Molecular Properties
| Compound Name | 2,2-difluoro-3-hydroxy-6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-3,5-dihydrofuro[3,2-f]isoindol-7-one;3,3-difluoro-7-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-2,8-dihydro-[1,4]dioxino[2,3-f]isoindol-6-one;2,2-dimethyl-6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-5H-[1,3]dioxolo[4,5-f]isoindol-7-one;6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]spiro[3,5-dihydrofuro[3,2-f]isoindole-2,1'-cyclobutane]-7-one;6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]spiro[5H-[1,3]dioxolo[4,5-f]isoindole-2,1'-cyclobutane]-7-one;6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]spiro[5H-[1,3]dioxolo[4,5-f]isoindole-2,1'-cyclopropane]-7-one |
|---|---|
| PubChem CID | 158838584 |
| Molecular Formula | C133H124F4N24O17 |
| Molecular Weight | 2406.60 g/mol |
| Exact Mass | 2404.95 |
| IUPAC Name | 2,2-difluoro-3-hydroxy-6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-3,5-dihydrofuro[3,2-f]isoindol-7-one;3,3-difluoro-7-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-2,8-dihydro-[1,4]dioxino[2,3-f]isoindol-6-one;2,2-dimethyl-6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-5H-[1,3]dioxolo[4,5-f]isoindol-7-one;6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]spiro[3,5-dihydrofuro[3,2-f]isoindole-2,1'-cyclobutane]-7-one;6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]spiro[5H-[1,3]dioxolo[4,5-f]isoindole-2,1'-cyclobutane]-7-one;6-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]spiro[5H-[1,3]dioxolo[4,5-f]isoindole-2,1'-cyclopropane]-7-one |
| SMILES | CC(C)n1ccnc1-c1cccc(N2Cc3cc4c(cc3C2=O)OC(C)(C)O4)n1.CC(C)n1ccnc1-c1cccc(N2Cc3cc4c(cc3C2=O)OC(F)(F)C4O)n1.CC(C)n1ccnc1-c1cccc(N2Cc3cc4c(cc3C2=O)OC(F)(F)CO4)n1.CC(C)n1ccnc1-c1cccc(N2Cc3cc4c(cc3C2=O)OC2(CC2)O4)n1.CC(C)n1ccnc1-c1cccc(N2Cc3cc4c(cc3C2=O)OC2(CCC2)C4)n1.CC(C)n1ccnc1-c1cccc(N2Cc3cc4c(cc3C2=O)OC2(CCC2)O4)n1 |
| InChI | InChI=1S/C24H24N4O2.C23H22N4O3.C22H20N4O3.C22H22N4O3.2C21H18F2N4O3/c1-15(2)27-10-9-25-22(27)19-5-3-6-21(26-19)28-14-17-11-16-13-24(7-4-8-24)30-20(16)12-18(17)23(28)29;1-14(2)26-10-9-24-21(26)17-5-3-6-20(25-17)27-13-15-11-18-19(12-16(15)22(27)28)30-23(29-18)7-4-8-23;1-13(2)25-9-8-23-20(25)16-4-3-5-19(24-16)26-12-14-10-17-18(11-15(14)21(26)27)29-22(28-17)6-7-22;1-13(2)25-9-8-23-20(25)16-6-5-7-19(24-16)26-12-14-10-17-18(11-15(14)21(26)27)29-22(3,4)28-17;1-12(2)26-7-6-24-19(26)15-4-3-5-18(25-15)27-10-13-8-16-17(9-14(13)20(27)28)30-21(22,23)11-29-16;1-11(2)26-7-6-24-19(26)15-4-3-5-17(25-15)27-10-12-8-14-16(9-13(12)20(27)29)30-21(22,23)18(14)28/h3,5-6,9-12,15H,4,7-8,13-14H2,1-2H3;3,5-6,9-12,14H,4,7-8,13H2,1-2H3;3-5,8-11,13H,6-7,12H2,1-2H3;5-11,13H,12H2,1-4H3;3-9,12H,10-11H2,1-2H3;3-9,11,18,28H,10H2,1-2H3 |
| InChIKey | IXYHXWNVKDLIKN-UHFFFAOYSA-N |
| XLogP | 24.78 |
| TPSA | 418.65 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 18 |
| Heavy Atoms | 178 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2406.60 |
| LogP ≤ 5 | 24.78 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 35 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158838584 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.